| Literature DB >> 24064717 |
Katherine E Zychowski1, Aline Rodrigues Hoffmann, Hoai J Ly, Camilo Pohlenz, Alejandro Buentello, Amelia Romoser, Delbert M Gatlin, Timothy D Phillips.
Abstract
Aflatoxin B1 (AFB1) is a potent carcinogen that causes growth stunting, immunosuppression and liver cancer in multiple species. The recent trend of replacing fishmeal with plant-based proteins in fish feed has amplified the AFB1 exposure risk in farm-raised fish. NovaSil (NS), a calcium montmorillonite clay, has previously been shown to reduce AFB1 bioavailability safely and efficaciously in several mammalian species. This study was designed to: (1) evaluate AFB1 impact on cultured red drum, Sciaenops ocellatus, over the course of seven weeks; and (2) assess NS supplementation as a strategy to prevent aflatoxicosis. Fish were fed diets containing 0, 0.1, 0.25, 0.5, 1, 2, 3, or 5 ppm AFB1. Two additional treatment groups were fed either 5 ppm AFB1 + 1% NS or 5 ppm AFB1 + 2% NS. Aflatoxin B1 negatively impacted red drum weight gain, survival, feed efficiency, serum lysozyme concentration, hepatosomatic index (HSI), whole-body lipid levels, liver histopathological scoring, as well as trypsin inhibition. NovaSil inclusion in AFB1-contaminated diets improved weight gain, feed efficiency, serum lysozyme concentration, muscle somatic index, and intraperitoneal fat ratios compared to AFB1-treated fish. Although not significant, NS reduced AFB1-induced histopathological changes in the liver and decreased Proliferating Cell Nuclear Antigen (PCNA) staining. Importantly, NS supplementation improved overall health of AFB1-exposed red drum.Entities:
Mesh:
Substances:
Year: 2013 PMID: 24064717 PMCID: PMC3798873 DOI: 10.3390/toxins5091555
Source DB: PubMed Journal: Toxins (Basel) ISSN: 2072-6651 Impact factor: 4.546
Growth performance of red drum fed different concentrations of Aflatoxin B1 (AFB1) 1 and AFB1 + NovaSil (NS) 2,3,4.
| Variable | Weight gain 5 (%) | Survival (%) | Feed efficiency | Variable | Weight gain (%) | Survival (%) | Feed efficiency | |
|---|---|---|---|---|---|---|---|---|
| AFB1 (ppm) | Individual treatment means | AFB1 (ppm) | NS (%) | Individual treatment means | ||||
| 0 | 332 a | 80.0 a | 0.91 a | 0 | 0 | 332 ab | 80.0 | 0.91 a |
| 0.1 | 223 bc | 46.6 b | 0.62 bc | 5 | 0 | 188 c | 55.5 | 0.62 c |
| 0.25 | 224 bc | 55.5 b | 0.65 bc | 5 | 1 | 339 a | 73.3 | 0.82 ab |
| 0.5 | 254 ab | 60.0 ab | 0.75 ab | 5 | 2 | 218 bc | 57.7 | 0.71 bc |
| 1 | 212 bc | 60.0 ab | 0.73 abc | 0.039 | 0.261 | 0.005 | ||
| 2 | 136 c | 60.0 ab | 0.49 c | Pooled Std. Error | 7.047 | 1.801 | 0.008 | |
| 3 | 183 bc | 62.2 ab | 0.67 bc |
|
|
| ||
| 5 | 188 bc | 55.5 b | 0.62 bc | 0 | 332 | 80.0 | 0.91 a | |
|
| 0.229 | 0.010 | 0.100 | 5 | 249 | 62.2 | 0.72 b | |
| 0.005 | 0.132 | 0.030 | 0 | 260 a | 67.7 | 0.77 | ||
| Pooled Std. Error | 5.189 | 1.309 | 0.013 | 1 | 339 ab | 73.3 | 0.82 | |
| 2 | 218 b | 57.7 | 0.71 | |||||
|
| ||||||||
|
| 0.083 | 0.138 | 0.003 | |||||
|
| 0.043 | 0.387 | 0.029 | |||||
1 Aflatoxin B1; 2 NovaSil; 3 Values are means of three replicate groups of fish (n = 3); 4 Values in a column that do not have the same superscript are significantly different according to Duncan’s multiple range test (p < 0.05); 5 Initial average weight was 2.1 ± 0.1 g/fish.
Immune parameters of red drum 1.
| Variable | Serum lysozyme (units/mL) | NBT (mg/mL blood) 2 | Trypsin inhibition (%) | Variable | Serum Lysozyme (units/mL) | NBT (mg/mL blood) 2 | Trypsin inhibition (%) | |
|---|---|---|---|---|---|---|---|---|
| AFB1 (ppm) | Individual treatment means | AFB1 (ppm) | NS (%) | Individual treatment means | ||||
| 0 | 165 ab | 3.52 | 83.6 ab | 0 | 0 | 165 ab | 3.52 | 83.6 |
| 0.1 | 246 a | 3.35 | 82.4 b | 5 | 0 | 45 c | 3.07 | 81.9 |
| 0.25 | 131 bcd | 2.54 | 86.3 a | 5 | 1 | 76b c | 3.32 | 81.3 |
| 0.5 | 155 abc | 3.30 | 83.2 b | 5 | 2 | 185 a | 3.21 | 79.4 |
| 1 | 106 bcd | 1.78 | 81.9 b | 0.024 | 0.944 | 0.577 | ||
| 2 | 82 bcd | 3.05 | 80.5 b | Pooled Std. Error | 5.550 | 0.104 | 0.395 | |
| 3 | 63 cd | 2.21 | 82.7 b |
|
|
| ||
| 5 | 45 d | 3.07 | 81.9 b | 0 | 165 | 3.52 | 83.6 | |
|
| 0.394 | 0.015 | 0.109 | 5 | 102 | 3.20 | 80.9 | |
| 0.004 | 0.250 | 0.038 | 0 | 105 | 3.30 | 82.7 | ||
| Pooled Std. Error | 5.705 | 0.102 | 0.192 | 1 | 76 | 3.32 | 81.3 | |
| 2 | 185 | 3.21 | 79.4 | |||||
|
| ||||||||
|
| 0.018 | 0.622 | 0.291 | |||||
|
| 0.021 | 0.948 | 0.674 | |||||
1 Values in a column that do not have the same superscript letters are significantly different according to Duncan’s multiple range test (p < 0.05); 2 Values are means of determinations on two fish from each of three replicate groups (6 fish/treatment, n = 6).
Somatic indices of red drum fed different concentrations of AFB1 1 and AFB1 + NS 2,3,4.
| Variable | Spleen | MSI 5 | HSI 6 | IPF 7 | Variable | Spleen | MSI 5 | HSI 6 | IPF 7 | |
|---|---|---|---|---|---|---|---|---|---|---|
| AFB1 (ppm) | Individual treatment means | AFB1 (ppm) | NS (%) | Individual treatment means | ||||||
| 0 | 0.04 | 28.94 | 1.67 abc | 0.32 | 0 | 0 | 0.04 | 28.94 a | 1.67 | 0.32 a |
| 0.1 | 0.04 | 27.42 | 1.98 a | 0.11 | 5 | 0 | 0.04 | 26.06 b | 0.88 | 0.01 b |
| 0.25 | 0.04 | 26.18 | 1.79 ab | 0.20 | 5 | 1 | 0.09 | 28.33 ab | 0.82 | 0.10 b |
| 0.5 | 0.05 | 27.87 | 1.20 abc | 0.26 | 5 | 2 | 0.20 | 29.70 a | 1.56 | 0.46 a |
| 1 | 0.03 | 27.79 | 1.15 abc | 0.07 | 0.528 | 0.031 | 0.292 | 0.003 | ||
| 2 | 0.18 | 26.25 | 0.72 c | 0.18 | Pooled Std. Error | 0.015 | 0.135 | 0.070 | 0.012 | |
| 3 | 0.05 | 25.72 | 0.94 abc | 0.06 |
|
|
| |||
| 5 | 0.04 | 26.06 | 0.88 bc | 0.01 | 0 | 0.04 | 28.94 | 1.67 | 0.32 | |
|
| 0.004 | 0.141 | 0.267 | 0.152 | 5 | 0.11 | 28.03 | 1.09 | 0.19 | |
| 0.503 | 0.417 | 0.091 | 0.466 | 0 | 0.04 | 27.50 | 1.27 | 0.17 a | ||
| Pooled Std. Error | 0.015 | 0.315 | 0.091 | 0.03 | 1 | 0.09 | 28.33 | 0.82 | 0.10 a | |
| 2 | 0.20 | 29.70 | 1.56 | 0.46 b | ||||||
|
| ||||||||||
|
| 0.494 | 0.298 | 0.205 | 0.112 | ||||||
|
| 0.429 | 0.019 | 0.332 | 0.002 | ||||||
1 Aflatoxin B1; 2 NovaSil; 3 Values in a column that do not have the same superscript letters are significantly different according to Duncan’s multiple range test (p < 0.05); 4 Values are means of determinations on two fish from each of three replicate groups (6 fish/treatment, n = 6); 5 Muscle somatic index; 6 Hepatosomatic index; 7 Intraperitoneal fat.
Proximate composition of red drum (fresh-weight basis) 1,2.
| Variable | % Lipid | % Protein | % Moisture | % Ash | Variable | % Lipid | % Protein | % Moisture | % Ash | |
|---|---|---|---|---|---|---|---|---|---|---|
| AFB1 (ppm) | Individual treatment means | AFB1 (ppm) | NS (%) | Individual treatment means | ||||||
| 0 | 2.70 a | 76.01 | 78.38 | 16.38 ab | 0 | 0 | 2.21 | 76.01 | 78.30 | 3.54 |
| 0.1 | 2.37 ab | 74.45 | 79.34 | 17.56 a | 5 | 0 | 1.98 | 76.52 | 79.29 | 3.73 |
| 0.25 | 1.97 bcd | 70.06 | 79.67 | 13.64 b | 5 | 1 | 2.20 | 73.92 | 76.91 | 4.28 |
| 0.5 | 2.42 ab | 74.33 | 77.69 | 16.72 ab | 5 | 2 | 2.19 | 72.93 | 79.04 | 4.35 |
| 1 | 2.17 abc | 71.64 | 78.71 | 18.04 a | 0.510 | 0.723 | 0.173 | 0.629 | ||
| 2 | 1.45 d | 74.20 | 84.55 | 19.43 a | Pooled Std. Error | 0.022 | 0.488 | 0.140 | 0.098 | |
| 3 | 1.77 cd | 71.64 | 80.60 | 17.22 a |
|
|
| |||
| 5 | 1.98 bcd | 76.52 | 79.29 | 18.02 a | 0 | 2.21 | 76.01 | 78.38 | 3.54 | |
|
| 0.211 | 0.021 | 0.024 | 0.109 | 5 | 2.12 | 74.46 | 78.41 | 4.12 | |
| 0.002 | 0.476 | 0.452 | 0.038 | 0 | 2.10 | 76.20 | 78.83 | 3.64 | ||
| Pooled Std. Error | 0.033 | 0.441 | 0.402 | 1.728 | 1 | 2.20 | 73.90 | 76.91 | 4.28 | |
| 2 | 2.19 | 72.90 | 79.04 | 4.35 | ||||||
|
| ||||||||||
|
| 0.534 | 0.611 | 0.964 | 0.357 | ||||||
|
| 0.394 | 0.604 | 0.095 | 0.663 | ||||||
1 Values are means of determinations on three fish from each of the three replicates (n =3). 2 Values in a column that do not have the same superscript letters are significantly different according to Duncan’s multiple range test (p < 0.05).
Histopathology and immunohistochemistry.
| Variable | Histology Score 1 | PCNA | Variable | Histology Score | PCNA | |
|---|---|---|---|---|---|---|
| AFB1 (ppm) | Individual treatment means | AFB1 (ppm) | NS (%) | Individual treatment means | ||
| 0 | 5.25 a | 6.27 | 0 | 0 | 13.16 ab | 6.27 |
| 0.1 | 10.67 a | 8.59 | 5 | 0 | 19.00 b | 10.49 |
| 0.25 | 17.33 ab | 9.35 | 5 | 1 | 9.16 a | 9.11 |
| 0.5 | 30.16 c | 11.34 | 5 | 2 | 7.66 a | 9.72 |
| 1 | 25.83 bc | 9.52 | 0.0925 | 0.7542 | ||
| 2 | 31.83 c | 9.06 | Pooled Std. Error | 0.838 | 0.836 | |
| 3 | 37.00 c | 10.30 |
|
|
| |
| 5 | 37.00 c | 10.49 | 0 | 13.16 | 6.27 | |
|
| 0.2353 | 0.0204 | 5 | 11.94 | 9.78 | |
| 0.0001 | 0.5059 | 0 | 16.08 | 8.38 | ||
| Pooled Std. Error | 1.130 | 0.815 | 1 | 9.16 | 9.11 | |
| 2 | 7.66 | 9.72 | ||||
|
| ||||||
|
| 0.7248 | 0.3251 | ||||
|
| 0.0491 | 0.9454 | ||||
1 Values in a column that do not have the same superscript letters are significantly different according to Duncan’s multiple; range test (p < 0.05).
Figure 1Liver histopathology in AFB1-exposed red drum. Liver sections were stained with hematoxylin and eosin. Treatments were as follows: (A) 0 ppm AFB1 (B) 1 ppm AFB1 (C) 3 ppm (D) 5 ppm AFB1 (E) AFB1 + 1% NS and (F) 5 ppm AFB1 + 2% NS. Marked pleomorphism, megalokaryosis with prominent nucleoli (arrows) and loss of hepatocellular cytoplasmic macrovacuolation was observed in the treatment groups that received large amounts of aflatoxin (B,C,D). Although not significant, inclusion of NS resulted in decreased histopathological scores attributable to increased cytoplasmic vacuolation and reduced cellular pleomorphism.
Figure 2Proliferating Cell Nuclear Antigen (PCNA) positive cells in red drum hepatocytes. Liver sections were stained with PCNA (arrows) and hematoxylin counterstain. Treatments were as follows: (A) 0 ppm AFB1 (B) 1 ppm AFB1 (C) 3 ppm AFB1 (D) 5 ppm AFB1 (E) 5 ppm AFB1 + 1% NS (F) 5 ppm AFB1 + 2% NS. Although not significant, inclusion of NS resulted in a decrease of PCNA-positive hepatocytes. Reduction in cell proliferation suggests that NS afforded some protection from AFB1 toxicity and cellular proliferation.
Ingredient and proximate composition of experimental diets (g/100 g of dry weight).
| Level of AFB1 (ppm) | 0 | 0.1 | 0.25 | 0.5 | 1 | 2 | 3 | 5 | 5 | 5 |
|---|---|---|---|---|---|---|---|---|---|---|
| Level of NS (%) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 2 |
| Menhaden Meal a | 34.9 | 34.9 | 34.9 | 34.9 | 34.9 | 34.9 | 34.9 | 34.9 | 34.9 | 34.9 |
| Soybean Meal b | 27.3 | 27.3 | 27.3 | 27.3 | 27.3 | 27.3 | 27.3 | 27.3 | 27.3 | 27.3 |
| Dextrinized Starch c | 16.0 | 16.5 | 16.5 | 16.5 | 16.5 | 16.5 | 16.5 | 16.5 | 16.5 | 16.5 |
| Menhaden Oil a | 5.6 | 5.6 | 5.6 | 5.6 | 5.6 | 5.6 | 5.6 | 5.6 | 5.6 | 5.6 |
| Vitamin Premix d | 3.0 | 3.0 | 3.0 | 3.0 | 3.0 | 3.0 | 3.0 | 3.0 | 3.0 | 3.0 |
| Mineral Premix c | 4.0 | 4.0 | 4.0 | 4.0 | 4.0 | 4.0 | 4.0 | 4.0 | 4.0 | 4.0 |
| CMC c | 2.0 | 2.0 | 2.0 | 2.0 | 2.0 | 2.0 | 2.0 | 2.0 | 2.0 | 2.0 |
| Glycine e | 1.0 | 1.0 | 1.0 | 1.0 | 1.0 | 1.0 | 1.0 | 1.0 | 1.0 | 1.0 |
| Lysine e | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| NS f | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 1.1 | 2.3 |
| AFB1-spiked Celufil g | 0.0 | 0.2 | 0.7 | 1.6 | 4.5 | 0.5 | 0.8 | 1.6 | 1.6 | 1.6 |
| Celufil e | 5.5 | 5.3 | 4.8 | 3.9 | 1.0 | 5.0 | 4.7 | 3.9 | 2.8 | 1.7 |
|
| ||||||||||
| Protein | 36.2 | 35.8 | 35.7 | 35.2 | 35.6 | 35.5 | 36.1 | 35.6 | 35.2 | 35.5 |
| Lipid | 9.5 | 9.3 | 10.3 | 10.4 | 10.7 | 10.6 | 10.6 | 10.7 | 10.7 | 11.1 |
| Dry Matter | 94.5 | 94.7 | 94.9 | 93.6 | 94.3 | 94.8 | 95.2 | 95.4 | 95.4 | 95.0 |
| Ash | 11.1 | 10.9 | 10.9 | 11.3 | 11.1 | 10.9 | 10.9 | 11.1 | 11.8 | 12.9 |
a Special Select, Omega Protein, Houston, TX, USA; b De-hulled, roasted/cooked and solvent extracted, Producers Cooperative Association, Bryan, TX; c MP Biomedicals LLC, Solon, OH; d Contains (as g kg−1): Ca(C6H10O6)·5H2O, 348.49; Ca(H2PO4)·2H2O, 136.0; FeSO4·7H2O, 5.0; MgSO4·7H2O, 132.0; K2HPO4, 240.0; NaH2PO4·H2O, 88.0; NaCl, 45.0; AlCl3 6H2O, 0.15; KI, 0.15; CuSO4·5H2O, 0.5; MnSO4·H2O, 0.7; CoCl2·6H2O, 1.0; ZnSO4·7H2O, 3.0; Na2SeO3, 0.011; e USB Corporation, Cleveland, OH; f Englehard Corporation, Jackson, MS; g Sigma-Aldrich, St. Louis, MO, USA.
Histological evaluation criteria.
| Score | Evaluation | Description |
|---|---|---|
| 0 | Normal | Intracytoplasmic vacuolation, mostly macrovacuolar with one of the control livers also having micro and macrovesiculation. Nuclei are small and pushed to the periphery with small nucleoli. |
| 1+ | Minimal | Scattered increase in nuclear size and mostly inconspicuous nucleoli. |
| 2+ | Mild | Mild hypertrophy and pleomorphism with slightly prominent nuclei and more evident nucleoli. Some loss of intracytoplasmic macrovacuoles, and formation of microvacuoles. |
| 3+ | Moderate | Moderate cellular pleomorphism, with anisocytosis, anisokaryosis, megalocytosis and megalokaryosis. Sparse intracytoplasmic vacuoles. |
| 4+ | Marked | Diffuse loss of cytoplasmic vacuolation, mostly solid cytoplasm. Marked pleomorphism, anisocytosis, anisokaryosis, megalocytosis and megalokaryosis. |